Loading...
In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent
Blastic plasmacytoid dendritic cell neoplasm is an aggressive malignancy derived from plasmacytoid dendritic cells. There is currently no accepted standard of care for treating this neoplasm, and therapeutic strategies have never been prospectively evaluated. Since blastic plasmacytoid dendritic cel...
Na minha lista:
| Udgivet i: | Haematologica |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Ferrata Storti Foundation
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4803130/ https://ncbi.nlm.nih.gov/pubmed/25381130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.111740 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|